Next Article in Journal

Weekends-Off Lenvatinib for Unresectable Hepatocellular Carcinoma Improves Therapeutic Response and Tolerability Toward Adverse Events

Next Article in Special Issue

Current Strategies and Future Perspectives for Precision Medicine in Pancreatic Cancer

Previous Article in Journal

Public Adverse Event Data Insights into the Safety of Pembrolizumab in Melanoma Patients

Previous Article in Special Issue

Personalized Medicine—Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.

Search for Articles:

Title / Keyword

Author / Affiliation / Email

Journal

Article Type

Advanced Search

Section

Special Issue

Volume

Issue

Number

Page

Logical OperatorOperator

Search Text

Search Type

Submit to this Journal Review for this Journal Propose a Special Issue

Article Menu

Share Help Cite Discuss in SciProfiles

Open AccessReview

Article Versions Notes

Cancers 2020, 12(4), 1009; https://doi.org/10.3390/cancers12041009

Action	Date	Notes	Link
article xml file uploaded	19 April 2020 15:50 CEST	Original file	-
article xml uploaded.	19 April 2020 15:50 CEST	Update	-
article pdf uploaded.	19 April 2020 15:50 CEST	Version of Record	https://www.mdpi.com/2072-6694/12/4/1009/pdf-vor
article html file updated	19 April 2020 15:52 CEST	Original file	-
article xml file uploaded	21 April 2020 09:18 CEST	Update	-
article xml uploaded.	21 April 2020 09:18 CEST	Update	https://www.mdpi.com/2072-6694/12/4/1009/xml
article pdf uploaded.	21 April 2020 09:18 CEST	Updated version of record	https://www.mdpi.com/2072-6694/12/4/1009/pdf
article html file updated	21 April 2020 09:19 CEST	Update	-
article html file updated	21 July 2022 02:24 CEST	Update	https://www.mdpi.com/2072-6694/12/4/1009/html

Back to TopTop